Aktoseril 200 mg/ml 5 ml N5 Amp

AKTOSERİL, solution for injection

AKTOSERİL composition

Active ingredient: 1 ampoule contains 200.0 mg of deproteinized calf blood extract.

Indications for use

It is indicated for the treatment of disorders of brain cell metabolism (including cerebral ischemia, brain dementia, brain injury, and cerebral dysfunction).

Contraindications

− Hypersensitivity to the Aktoseril preparation and similar preparations or to excipients, − severe renal impairment, oliguria, anuria − decompensated heart failure − pulmonary edema, infusion in cases of hyperhydration − children under 18 years of age.

Use during pregnancy and lactation

The preparation should be used with great caution during pregnancy and lactation.

Effect on the ability to drive vehicles and operate other potentially dangerous machinery

Not determined.

AKTOSERİL dosage and method of administration

The preparation should be administered intravenously by drip infusion. In patients with cerebral apoplexy and brain injury: 20–30 ml of the preparation should be diluted with 250 ml of 5% glucose solution or 0.9% sodium chloride solution, and administered once daily by slow intravenous drip infusion (drip rate <2 ml/min). The duration of treatment should be two weeks. In patients with brain dysfunction and brain dementia: 30 ml of the preparation should be diluted with 250 ml of 5% glucose solution or 0.9% sodium chloride solution, and administered once daily by slow intravenous drip infusion.

The duration of treatment should be two weeks.